AxoGen, Inc.
General ticker "AXGN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $696.7M (TTM average)
AxoGen, Inc. follows the US Stock Market performance with the rate: 28.2%.
Estimated limits based on current volatility of 4.5%: low 28.78$, high 31.52$
Factors to consider:
- Total employees count: 452 (+5.6%) as of 2024
- Top business risk factors: Operating inefficiencies and challenges, Leadership changes, Strategic risks and growth management, Geopolitical risks, Regulatory and compliance
- Current price 33.2% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [12.18$, 24.67$]
- 2025-12-31 to 2026-12-31 estimated range: [11.38$, 23.01$]
Financial Metrics affecting the AXGN estimates:
- Positive: with PPE of 114.8 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of -1.72
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 1.15 <= 3.41
- Positive: 41.86 < Shareholder equity ratio, % of 51.00 <= 63.39
- Negative: Inventory ratio change, % of 2.40 > 0.84
Short-term AXGN quotes
Long-term AXGN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $138.58MM | $159.01MM | $187.34MM |
| Operating Expenses | $168.29MM | $180.47MM | $190.62MM |
| Operating Income | $-29.71MM | $-21.46MM | $-3.29MM |
| Non-Operating Income | $0.76MM | $-0.25MM | $-6.68MM |
| Interest Expense | $0.62MM | $2.83MM | $8.21MM |
| R&D Expense | $25.63MM | $27.34MM | $27.77MM |
| Income(Loss) | $-28.95MM | $-21.72MM | $-9.96MM |
| Profit(Loss)* | $-28.95MM | $-21.72MM | $-9.96MM |
| Stockholders Equity | $101.00MM | $95.67MM | $103.91MM |
| Inventory | $18.91MM | $23.02MM | $33.18MM |
| Assets | $195.39MM | $196.83MM | $203.73MM |
| Operating Cash Flow | $-16.07MM | $-5.72MM | $4.54MM |
| Capital expenditure | $21.25MM | $14.92MM | $4.52MM |
| Investing Cash Flow | $-3.20MM | $19.25MM | $-10.30MM |
| Financing Cash Flow | $1.79MM | $1.95MM | $2.29MM |
| Earnings Per Share** | $-0.69 | $-0.51 | $-0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.